The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents

Detalles Bibliográficos
Autores principales: Honore, Patrick M., Mugisha, Aude, Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, De Bels, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218617/
https://www.ncbi.nlm.nih.gov/pubmed/32404187
http://dx.doi.org/10.1186/s13054-020-02947-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218617/
https://www.ncbi.nlm.nih.gov/pubmed/32404187
http://dx.doi.org/10.1186/s13054-020-02947-x

Ejemplares similares